TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
2,822
|
473
|
49 |
Financial expenses |
1,403
|
1,897
|
675 |
Earnings before taxes |
-21,091
|
-22,746
|
-17,743 |
EBITDA |
-17,557
|
-17,964
|
-14,261 |
Total assets |
14,869
|
21,701
|
25,810 |
Current assets |
7,198
|
11,818
|
13,436 |
Current liabilities |
3,838
|
7,709
|
1,893 |
Equity capital |
11,031
|
13,992
|
23,917 |
- share capital |
8,969
|
6,007
|
4,815 |
Employees (average) |
6
![]() |
6
|
7 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
74.2%
|
64.5%
|
92.7% |
Turnover per employee |
470
|
79
|
7 |
Profit as a percentage of turnover |
-747.4%
|
-4808.9%
|
-36210.2% |
Return on assets (ROA) |
-132.4%
|
-96.1%
|
-66.1% |
Current ratio |
187.5%
|
153.3%
|
709.8% |
Return on equity (ROE) |
-191.2%
|
-162.6%
|
-74.2% |
Change turnover |
2,349
|
424
|
-82 |
Change turnover % |
497%
|
865%
|
-63% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-14%
|
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.